Subtraction method for determination of N-terminal connective tissue growth factor

Annals of Clinical Biochemistry

Volumn 47, Issue 3, 2010, Pages 205-211

  Miyazaki, Osamu ^a   Kurashita, Syunsuke ^a   Fukamachi, Isamu ^a   Endo, Koki ^b   Ng, Poh Sing ^b   Takehara, Kazuhiko ^c  

^a SEKISUI CHEMICAL CO LTD   (Japan)

^b Nosan Corporation   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE SUBTRACTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; ANTIBODIES, MONOCLONAL; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 77951826844     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.009182     Document Type: Article

References (20)

1. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004;363:62-64 (Pubitemid 38076928)
2. de Winter P, Leoni P, Abraham D. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 2008;26:80-91 (Pubitemid 351584060)
3. Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003;81:355-363 (Pubitemid 38186975)
4. Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003;26:1-9 (Pubitemid 36939924)
5. Roestenberg P, van Nieuwenhoven FA, Wieten L, et al. Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 2004;27:1164-1170 (Pubitemid 38579784)
6. Kunzmann S, Schmidt-Weber C, Zingg JM, et al. Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: potential role of histamine in airway remodeling. J Allergy Clin Immunol 2007;119:1398-1407 (Pubitemid 46855848)
7. Koitabashi N, Arai M, Niwano K, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Failure 2008;10:373-379
8. Sato S, Nagaoka T, Hasegawa M, et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 2000;27:149-154 (Pubitemid 30058642)
9. Cicha I, Garlichs CD, Daniel WG, Goppelt-Struebe M. Activated human platelets release connective tissue growth factor. Thromb Haemost 2004;91:755-760 (Pubitemid 38477456)
10. Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M. Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem 2004;136:279-282 (Pubitemid 39545786)
11. Lau CP, Tse HF, Cheng G. Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients. Heart 1997;78:358-363 (Pubitemid 27479637)
12. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med 1996;239:17-34 (Pubitemid 26022569)
13. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199-202 (Pubitemid 11174877)
14. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992;356:152-154
15. Ikawa Y, Ng PS, Endo K, et al. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis. J Cell Physiol 2008;216:680-687
16. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497
17. Axel GM, Eray Y, Birgit L, Olav G, Sven S. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem 2006;52:1815-1817 (Pubitemid 44330719)
18. Tamatani T, Kobayashi H, Tezuka K, et al. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun 1998;251:748-752 (Pubitemid 28512782)
19. Kawaki H, Kubota S, Minato M, et al. Novel enzyme-linked immunosorbent assay systems for the quantitative analysis of connective tissue growth factor (CTGF/Hcs24/CCN2): detection of HTLV-I tax-induced CTGF from a human carcinoma cell line. DNA Cell Biol 2003;22:641-648 (Pubitemid 37357734)
20. Dziadzio M, Usinger W, Leask A, et al. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. Q J Med 2005;98:485-492 (Pubitemid 41418671)